Relationship between brain accumulation of manganese and aberration of hippocampal adult neurogenesis after oral exposure to manganese chloride in mice

Toxicology. 2015 May 4:331:24-34. doi: 10.1016/j.tox.2015.02.005. Epub 2015 Feb 16.

Abstract

We previously found persistent aberration of hippocampal adult neurogenesis, along with brain manganese (Mn) accumulation, in mouse offspring after developmental exposure to 800-ppm dietary Mn. Reduction of parvalbumin (Pvalb)(+) γ-aminobutyric acid (GABA)-ergic interneurons in the hilus of the dentate gyrus along with promoter region hypermethylation are thought to be responsible for this aberrant neurogenesis. The present study was conducted to examine the relationship between the induction of aberrant neurogenesis and brain Mn accumulation after oral Mn exposure as well as the responsible mechanism in young adult animals. We used two groups of mice with 28- or 56-day exposure periods to oral MnCl2·xH2O at 800 ppm as Mn, a dose sufficient to lead to aberrant neurogenesis after developmental exposure. A third group of mice received intravenous injections of Mn at 5-mg/kg body weight once weekly for 28 days. The 28-day oral Mn exposure did not cause aberrations in neurogenesis. In contrast, 56-day oral exposure caused aberrations in neurogenesis suggestive of reductions in type 2b and type 3 progenitor cells and immature granule cells in the dentate subgranular zone. Brain Mn accumulation in 56-day exposed cases, as well as in directly Mn-injected cases occurred in parallel with reduction of Pvalb(+) GABAergic interneurons in the dentate hilus, suggesting that this may be responsible for aberrant neurogenesis. For reduction of Pvalb(+) interneurons, suppression of brain-derived neurotrophic factor-mediated signaling of mature granule cells may occur via suppression of c-Fos-mediated neuronal plasticity due to direct Mn-toxicity rather than promoter region hypermethylation of Pvalb.

Keywords: BDNF; GABAergic interneuron; Hippocampal adult neurogenesis; Manganese.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Animals
  • Biomarkers / metabolism
  • Brain-Derived Neurotrophic Factor / genetics
  • Brain-Derived Neurotrophic Factor / metabolism
  • Chlorides / administration & dosage
  • Chlorides / metabolism
  • Chlorides / toxicity*
  • GABAergic Neurons / drug effects*
  • GABAergic Neurons / metabolism
  • GABAergic Neurons / pathology
  • Gene Expression Regulation
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Hippocampus / pathology
  • Hippocampus / physiopathology
  • Interneurons / drug effects*
  • Interneurons / metabolism
  • Interneurons / pathology
  • Manganese Compounds / administration & dosage
  • Manganese Compounds / metabolism
  • Manganese Poisoning / etiology*
  • Manganese Poisoning / genetics
  • Manganese Poisoning / metabolism
  • Manganese Poisoning / pathology
  • Manganese Poisoning / physiopathology
  • Mice, Inbred ICR
  • Neural Stem Cells / drug effects*
  • Neural Stem Cells / metabolism
  • Neural Stem Cells / pathology
  • Neurogenesis / drug effects*
  • Neuronal Plasticity / drug effects
  • Parvalbumins / genetics
  • Parvalbumins / metabolism
  • Promoter Regions, Genetic
  • Proto-Oncogene Proteins c-fos / metabolism
  • Time Factors
  • gamma-Aminobutyric Acid / metabolism

Substances

  • Biomarkers
  • Brain-Derived Neurotrophic Factor
  • Chlorides
  • Manganese Compounds
  • Parvalbumins
  • Proto-Oncogene Proteins c-fos
  • gamma-Aminobutyric Acid
  • manganese chloride